Physician profile
Lisa Shin
NPI 1427150994
$1,282.29
in general payments reported to CMS, 2019-2025
10 companies · $788 in 2025
The $788 reported for 2025 was more than what 87% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $49.75 · 2021: $136 · 2022: $207 · 2025: $788.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $788.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $610.63 | 2025 | Optilight |
| Bausch & Lomb Americas INC. | $161.99 | 2025 | Vyzulta, Miebo, Biotrue |
| Regeneron Healthcare Solutions, INC. | $119.85 | 2021 | |
| Dompe US, INC. | $109.74 | 2022 | |
| Coopervision INC. | $93.29 | 2022-2025 | Synergeyes Contact Lens |
| Alcon Vision LLC | $90.41 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $40.58 | 2019-2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Abbvie INC. | $19.16 | 2022 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Shin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.